Richard Douglas, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 5,000 shares at $6.00 ($30K) on 2019-09-13, disclosed to the SEC on 2019-09-17.
Open-market purchase of $30k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| MXCT | BUY | 2023-03-30 | $346K | — | Filing → |
| MXCT | BUY | 2021-11-23 | $445K | — | Filing → |
| ALDX | BUY | 2020-03-17 | $110K | — | Filing → |